Importantly, modeling studies estimate that VMAT2 density may begin to decline 15–20 years before the onset of motor symptoms, underscoring its potential to track the pre-symptomatic phase of PD [76,77]. The gene discussed is SLC18A2; the disease is Parkinson disease.